Counselling issues in familial hypertrophic cardiomyopathy
- PMID: 9541100
- PMCID: PMC1051239
- DOI: 10.1136/jmg.35.3.183
Counselling issues in familial hypertrophic cardiomyopathy
Abstract
To illustrate the variable clinical presentations and rates of progression in familial hypertrophic cardiomyopathy (FHC), phenotypes and genotypes were compared in three FHC families with different genetic defects. In the first family, the FHC abnormality was a protein truncating mutation (Gln969X) in the cardiac myosin binding protein C gene. The second family had a missense change (Asn755Lys) in the same gene. A missense mutation (Arg453Cys) in the cardiac beta myosin heavy chain gene was present in the third family. Penetrance associated with the Gln969X defect was 27% in the age range 0 to 40 years. This was considerably less than the 93% penetrance (0 to 40 years) observed in the two families with missense mutations. The variable penetrance in FHC, as well as the unpredictability of sudden cardiac death, complicates clinical diagnosis and management, including genetic counselling. Although a genetic disease with a predominantly adult onset, there are counselling issues in FHC which set it aside from other adult onset disorders.
Similar articles
-
Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.Br Heart J. 1995 Jul;74(1):40-6. doi: 10.1136/hrt.74.1.40. Br Heart J. 1995. PMID: 7662452 Free PMC article.
-
Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.N Engl J Med. 1998 Apr 30;338(18):1248-57. doi: 10.1056/NEJM199804303381802. N Engl J Med. 1998. PMID: 9562578
-
Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation.Am J Cardiol. 1999 Jun 17;83(12A):13H-18H. doi: 10.1016/s0002-9149(99)00251-9. Am J Cardiol. 1999. PMID: 10750581
-
[Genotype-phenotype correlations in familial hypertrophic cardiomyopathy].Nihon Rinsho. 2000 Jan;58(1):134-40. Nihon Rinsho. 2000. PMID: 10885301 Review. Japanese.
-
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.J Am Coll Cardiol. 2012 Aug 21;60(8):705-15. doi: 10.1016/j.jacc.2012.02.068. Epub 2012 Jul 11. J Am Coll Cardiol. 2012. PMID: 22796258 Review.
Cited by
-
Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and Long QT syndrome: a qualitative study of patient experiences.J Genet Couns. 2010 Dec;19(6):630-9. doi: 10.1007/s10897-010-9314-0. Epub 2010 Aug 3. J Genet Couns. 2010. PMID: 20680418
-
Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.Circ Heart Fail. 2009 May;2(3):253-61. doi: 10.1161/CIRCHEARTFAILURE.108.817346. Circ Heart Fail. 2009. PMID: 19808347 Free PMC article. Review.
-
Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.J Clin Pathol. 2005 May;58(5):479-85. doi: 10.1136/jcp.2004.021642. J Clin Pathol. 2005. PMID: 15858117 Free PMC article.
-
Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.J Genet Couns. 2001 Oct;10(5):397-415. doi: 10.1023/A:1016641504606. J Genet Couns. 2001. PMID: 26141267
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical